Form 483

Stericycle Inc Form 483, 2020-02-27

FDA issued a Form 483 to Stericycle Inc on 2020-02-27 with 6 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health6 observations

Stericycle Inc · Bannockburn, United States · Issued February 27, 2020

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Feb 2020
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Jesse A Vazquez, Javelle P Spann

27 Feb 2020
21 CFR 820.20(a)

Quality policy and objectives

Cited by Jesse A Vazquez, Javelle P Spann

27 Feb 2020
21 CFR 820.20(b)

Lack of or inadequate organizational structure

Cited by Jesse A Vazquez, Javelle P Spann

27 Feb 2020
21 CFR 820.22

Quality audits - Lack of or inadequate procedures

Cited by Jesse A Vazquez, Javelle P Spann

27 Feb 2020
21 CFR 820.40(b)

Change records, content

Cited by Jesse A Vazquez, Javelle P Spann

Inspected site

SIStericycle IncBannockburn, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.20(a)Cited across public-safe Form 483 observations1x
21 CFR 820.20(b)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.40(b)Cited across public-safe Form 483 observations1x
21 CFR 820.70(i)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere